What are the first-line pharmacologic treatments for Opioid Use Disorder and their mechanisms?

• A. Methadone, Buprenorphine, and Naltrexone (all first-line) with their mechanisms as described.
• B. Methadone and Naltrexone only; Buprenorphine is not used.
• C. Methadone (full mu-opioid receptor agonist); Buprenorphine (partial mu-agonist with ceiling effect; often combined with naloxone); Naltrexone (opioid receptor antagonist for relapse prevention after detox).
• D. Naloxone is the only first-line agent for maintenance therapy.

Answer: (C)

The main idea here is that several medications are considered first-line options for opioid use disorder because each helps reduce withdrawal, cravings, and the risk of relapse, but they do so in different ways and are used at different points in treatment.

Methadone is a full mu-opioid receptor agonist with a long duration of action. By activating the receptor, it smooths withdrawal and blunts cravings, allowing people to stabilize and engage in ongoing treatment. Its full agonist effect means it can substitute for other opioids and prevent the roller-coaster of withdrawal and drug-seeking, but it requires careful dosing and monitoring in specialized programs.

Buprenorphine is a partial mu-opioid receptor agonist with a ceiling effect. This means it provides enough receptor activation to relieve withdrawal and cravings but has a limited risk of severe respiratory depression, making it safer in many scenarios. It’s often formulated with naloxone (to deter injection misuse) and can be prescribed in office-based settings, which expands access for many patients.

Naltrexone is an opioid receptor antagonist. After a complete detox, it blocks the effects of opioids, helping prevent relapse. It’s not used during active withdrawal or while opioids are still in the person’s system because it can precipitate withdrawal; extended-release injectable forms can help with adherence.

Naloxone, by contrast, is primarily an overdose-reversal agent and is not used as a maintenance therapy for opioid use disorder, which is why a plan centered on naloxone alone would not be considered first-line maintenance treatment.

So, the best option pairs methadone, buprenorphine, and naltrexone with accurate mechanisms: methadone as a full agonist, buprenorphine as a partial agonist with a ceiling effect (often with naloxone), and naltrexone as an antagonist used after detox to prevent relapse.